Literature DB >> 24247567

The prevalence of small intestinal bacterial overgrowth and methane production in patients with myelomeningocele and constipation.

V Ojetti1, G Bruno1, V Paolucci2, S Triarico2, F D'aversa1, E Ausili2, A Gasbarrini1, C Rendeli2.   

Abstract

STUDY
DESIGN: Prospective study.
OBJECTIVES: The objective of this study was to assess the prevalence of small intestinal bacterial overgrowth (SIBO), methane (CH4) production and orocecal transit time (OCTT) in children affected by myelomeningocele.
SETTING: This study was conducted at the Catholic University in Rome, Italy.
METHODS: Eighteen (6M/12F; 16.4±7.6 years) children affected by myelomeningocele were enrolled. All subjects underwent H2/CH4 lactulose breath tests to assess SIBO and OCTT. All patients performed a visual analog scale to investigate abdominal pain, bloating and flatulence, and maintained a diary of the frequency and consistency of the stool during the previous 7 days. A nephro-urological clinical evaluation of the number of urinary tract infections (UTIs) and neurogenic bowel disease score were also performed.
RESULTS: Thirty-nine percent (7/18) of the children showed SIBO and 61% (11/18) presented a delayed OCTT. Moreover 44.4% (8/18) produced high levels of CH4. Interestingly, all myelomeningocele children who produced CH4 showed a delayed OCTT and a higher incidence of UTI, with a lower frequency of evacuation, compared with those with a normal or accelerated OCTT.
CONCLUSION: The association between CH4 and constipation suggests that CH4 has an active role in the development of constipation. One of the most interesting features of our study is to identify a correlation between myelomeningocele, CH4, delayed OCTT and UTI. The intestinal decontamination with locally acting drugs in these children may reduce the number of UTIs and improve intestinal motility.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24247567     DOI: 10.1038/sc.2013.131

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  7 in total

Review 1.  Malone Antegrade Continence Enemas vs. Cecostomy vs. Transanal Irrigation-What Is New and How Do We Counsel Our Patients?

Authors:  Maryellen S Kelly
Journal:  Curr Urol Rep       Date:  2019-06-10       Impact factor: 3.092

2.  Gut microbiota and pediatric patients with spina bifida and neurogenic bowel dysfunction.

Authors:  Claudia Rendeli; Valentina Filomena Paradiso; Valeria Bucci; Giuseppe Cretì; Carmen D'Aleo; Gabriele Lisi; Laura Lombardi; Antonio Marte; Giuseppe Masnata; Lucia Migliazza; Simona Gerocarni Nappo; Alessandro Raffaele; Dayana Stephanie Buzle; Elisa Viciani; Andrea Castagnetti; Emanuele Ausili
Journal:  Childs Nerv Syst       Date:  2022-09-30       Impact factor: 1.532

3.  Neurogenic bowel treatments and continence outcomes in children and adults with myelomeningocele.

Authors:  Maryellen S Kelly; John S Wiener; Tiebin Liu; Priya Patel; Heidi Castillo; Jonathan Castillo; Brad E Dicianno; Joan Jasien; Paula Peterson; Jonathan C Routh; Kathleen Sawin; Eileen Sherburne; Kathryn Smith; Asma Taha; Gordon Worley
Journal:  J Pediatr Rehabil Med       Date:  2020

4.  Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?

Authors:  Oana Belei; Laura Olariu; Andreea Dobrescu; Tamara Marcovici; Otilia Marginean
Journal:  J Neurogastroenterol Motil       Date:  2018-01-30       Impact factor: 4.924

Review 5.  Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.

Authors:  David Avelar Rodriguez; Paul MacDaragh Ryan; Erick Manuel Toro Monjaraz; Jaime Alfonso Ramirez Mayans; Eamonn Martin Quigley
Journal:  Front Pediatr       Date:  2019-09-04       Impact factor: 3.418

Review 6.  Functional Constipation and the Gut Microbiome in Children: Preclinical and Clinical Evidence.

Authors:  David Avelar Rodriguez; Jelena Popov; Elyanne M Ratcliffe; Erick Manuel Toro Monjaraz
Journal:  Front Pediatr       Date:  2021-01-20       Impact factor: 3.418

7.  Utility estimation for neurogenic bowel dysfunction in the general population.

Authors:  Kirsten L Simmons; Leah G Davis; Jonathan C Routh; Maryellen S Kelly
Journal:  J Pediatr Urol       Date:  2021-01-30       Impact factor: 1.921

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.